Our Strategy
Our investment objective is absolute returns with an effort to be tax efficient.
We monitor a universe of 300 public healthcare companies and invest in a select few. The majority are in the field of medical technology with the remainder in healthcare services lab tools and diagnostics. We have a long-bias. We tend to avoid companies with high valuations or that do not have approved products and revenues.
